Domestic stocks settled with modest gains following recent weakness in crude oil prices. The barometer index, the S&P BSE Sensex, rose 118.55 points or 0.34% to settle at 35,260.54. The Nifty 50 index rose 40.40 points or 0.38% to settle at 10,616.70.

The Sensex rose 118.55 points or 0.34% to settle at 35,260.54. The index hit high of 35,402 and low of 35,118.42 in intraday trade.

The Nifty 50 index rose 40.40 points or 0.38% to settle at 10,616.70. The index hit high of 10,646.50 and low of 10,557.50 in intraday trade.

Among secondary barometers, the BSE Mid-Cap index rose 0.74% to 14,992.48. The BSE Small-Cap index was flat at 14,548.04.

The market breadth, indicating the overall health of the market, was negative. On BSE, 1099 shares rose and 1497 shares fell. A total of 139 shares were unchanged.

Among the sectoral indices on BSE, the S&P BSE Consumer Durables index (up 1.6%), the S&P BSE Realty index (up 1.58%), the S&P BSE Bankex (up 0.79%) outperformed the Sensex. The S&P BSE FMCG index (down 0.21%), the S&P BSE Power index (down 0.17%), the S&P BSE Oil & Gas index (down 0.16%) underperformed the Sensex.

Adani Ports & Special Economic Zone (up 4.19%), Kotak Mahindra Bank (up 2.93%), Hero MotoCorp (up 2.2%), Axis Bank (up 2.11%) and Tata Motors (up 1.78%) were the major Sensex gainers.

NTPC (down 2.16%), ONGC (down 1.15%), Sun Pharmaceutical Industries (down 1.04%), Coal India (down 0.96%) and TCS (down 0.8%) were the major Sensex losers.

Yes Bank lost 7.42%. The bank informed that Ashok Chawla, non-executive independent part-time chairman, has tendered his resignation from the Bank's Board, with immediate effect, mentioning that during the current transition period, the Bank would need a Chairman who could devote more time and attention. The bank shall in due course announce the appointment of a Chairman, post RBI's approval. The announcement was made after market hours yesterday, 14 November 2018.

Grasim Industries lost 7.91% after the company reported consolidated net loss of Rs 1299.86 crore in Q2 September 2018 as compared with net profit of Rs 799.03 crore in Q2 September 2017. Total income rose 23.34% to Rs 17096.47 crore. The announcement was made after market hours yesterday, 14 November 2018.

The standalone loss after tax (after exceptional item) was Rs 1187 crore after considering a onetime non-cash exceptional item of Rs 2003 crore. The consolidated loss after tax (after exceptional items) was Rs 1446 crore.

With the merger of Vodafone India with Idea Cellular, Grasim Industries' shareholding in the merged entity, Vodafone Idea (VIL) now stands at 11.55%. Consequently, VIL ceased to be an ‘Associate' of the company with effect from 31 August 2018. Accordingly, the share in profit after tax of VIL has not been consolidated with effect from 31 August 2018. The exceptional item of Rs 2003 crore represents the difference between book value and fair value of VIL as on 30 August 2018. This has been charged to the Profit and Loss Account, consequent to VIL ceasing to be an ‘Associate'.

Lupin rose 1.34%. Lupin announced that it has received approval for its Decitabine for Injection, 50 mg/vial, Single-Dose Vial from the United States Food and Drug Administration (FDA) to market a generic version of Otsuka Pharmaceutical Co. Ltd.'s (Otsuka) Dacogen for Injection, 50 mg/vial, Single-Dose Vial. The announcement was made during market hours today, 15 November 2018.

Lupin's Decitabine for Injection , 50 mg/vial, Single-Dose Vial is the generic version of Otsuka's Dacogen for Injection, 50 mg/vial, Single-Dose Vial. It is indicated for the treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups. Decitabine for Injection, 50 mg/vial, Single-Dose Vial had annual sales of approximately $135.9 million in the US (IQVIA MAT September 2018).

Alkem Laboratories rose 0.71% after the company said that USFDA has concluded inspection at its Taloja facility. The announcement was made after market hours yesterday, 14 November 2018. Alkem Laboratories said that USFDA had conducted an inspection at the company's Bioequivalence facility located at Taloja, Maharashtra from 8 November 2018 to 14 November 2018. At the end of the inspection, no Form 483 was issued.

Realty stocks saw mixed trend. DLF (up 4.14%), Sunteck Realty (up 2.44%), Housing Development and Infrastructure (up 1.99%), Godrej Properties (up 4.76%) and Oberoi Realty (up 2.01%) rose.

Indiabulls Real Estate (down 4.74%), D B Realty (down 0.7%), Unitech (down 1.33%), Sobha (down 1.42%) and Prestige Estates Projects (down 1.53%) declined.

Oil India rose 0.37%. The company will consider and approve issuance of debt securities in domestic / overseas markets in its board meeting on 19 November 2018. The announcement was made after market hours yesterday, 14 November 2018.

NHPC lost 3.87% to Rs 26.05. The company's board approved buyback of 21.42 crore shares, representing 2.09% equity capital of the company at Rs 28 per share. The company has set 30 November 2018 as record date for buyback. The announcement was made after market hours yesterday, 14 November 2018.

In the global commodities markets, Brent for January 2019 settlement was off 4 cents at $66.08 a barrel. The contract rose 65 cents, or 0.99% to settle at $66.12 a barrel during the previous trading session.

India imports majority of its crude requirements and a decline in crude eases concerns on fiscal deficit, inflation and gives more room for the government to boost growth through spending on infrastructure.

Overseas, most European and Asian stock shares edged higher on Thursday as investors digest the latest news on Brexit. British Prime Minister Theresa May said she had obtained enough support for her proposed Brexit deal to move forward. The uncertainty surrounding a deal had earlier weighed on risk sentiment.

US stocks closed lower Wednesday, with the Dow Jones Industrial Average logging its longest losing streak in three months, as blue-chip Apple Inc. flirted with bear-market territory.

Meanwhile, US Federal Reserve Chairman Jerome Powell on Wednesday expressed confidence in US economic strength and said that markets will have to get used to the idea that the central bank could raise rates at any time starting in 2019.

On the US data front, the Labor Department said the consumer-price index rose by 0.3%, while core CPI, excluding volatile food and energy prices, rose 0.2%.